Key result
Targeted manganese micelles boost plaque MRI signal with a ~10-fold increase in relaxivity.
Why the study?
Oxidation-specific epitopes are critical in atherosclerosis, and gadolinium-based MRI agents have systemic toxicity concerns, motivating evaluation of biocompatible manganese probes for in vivo imaging.
Do targeted manganese molecular imaging probes improve MRI detection of oxidation-specific epitopes in atherosclerotic lesions in apoE(-/-) and LDLR(-/-) mice?
Do targeted manganese molecular imaging probes improve MRI detection of oxidation-specific epitopes in atherosclerotic lesions in apoE(-/-) and LDLR(-/-) mice?
Answers are grounded in this paper and cite their sources.
Biocompatible targeted manganese-based molecular imaging probes effectively detect oxidation-specific epitopes in atherosclerotic plaques, offering a potential alternative to gadolinium-based agents.
OBJECTIVES: This study sought to evaluate the in vivo magnetic resonance imaging (MRI) efficacy of manganese [Mn(II)] molecular imaging probes targeted to oxidation-specific epitopes (OSE). BACKGROUND: OSE are critical in the initiation, progression, and destabilization of atherosclerotic plaques. Gadolinium [Gd(III)]-based MRI agents can be associated with systemic toxicity. Mn is an endogenous, biocompatible, paramagnetic metal ion that has poor MR efficacy when chelated, but strong efficacy when released within cells. METHODS: Multimodal Mn micelles were generated to contain rhodamine for confocal microscopy and conjugated with either the murine monoclonal IgG antibody MDA2 targeted to malondialdehyde (MDA)-lysine epitopes or the human single-chain Fv antibody fragment IK17 targeted to MDA-like epitopes ("targeted micelles"). Micelle formulations were characterized in vitro and in vivo, and their MR efficacy (9.4-T) evaluated in apolipoprotein-deficient (apoE(-/-)) and low-density lipoprotein receptor negative (LDLR(-/-)) mice (0.05 mmol Mn/kg dose) (total of 120 mice for all experiments). In vivo competitive inhibition studies were performed to evaluate target specificity. Untargeted, MDA2-Gd, and IK17-Gd micelles (0.075 mmol Gd/kg) were included as controls. RESULTS: In vitro studies demonstrated that targeted Mn micelles accumulate in macrophages when pre-exposed to MDA-LDL with ∼10× increase in longitudinal relativity. Following intravenous injection, strong MR signal enhancement was observed 48 to 72 h after administration of targeted Mn micelles, with colocalization within intraplaque macrophages. Co-injection of free MDA2 with the MDA2-Mn micelles resulted in full suppression of MR signal in the arterial wall, confirming target specificity. Similar MR efficacy was noted in apoE(-/-) and LDLR(-/-) mice with aortic atherosclerosis. No significant differences in MR efficacy were noted between targeted Mn and Gd micelles. CONCLUSIONS: This study demonstrates that biocompatible multimodal Mn-based molecular imaging probes detect OSE within atherosclerotic plaques and may facilitate clinical translation of noninvasive imaging of human atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Briley‐Sæbø et al. (2012) studied Atherosclerosis (n=120). Targeted manganese [Mn(II)] molecular imaging probes vs. Untargeted, MDA2-Gd, and IK17-Gd micelles (0.075 mmol Gd/kg) was evaluated on In vivo magnetic resonance imaging (MRI) efficacy (MR signal enhancement). Targeted manganese micelles accumulated in macrophages with a ~10-fold increase in longitudinal relaxivity and provided strong in vivo MR signal enhancement of atherosclerotic plaques.
Synapse has enriched 10 related papers. Consider them for comparative context: